Safety and Efficacy of Luspatercept in Low-Risk Myelodysplastic Neoplasms with Anaemia
Background: Therapy of anaemia in people with low-risk Myelodysplastic Neoplasms (MDNs) is challenging. Luspatercept targets ineffective erythropoiesis. Objective: Define the safety and efficacy of luspatercept in people with low-risk MDNs and anaemia. Methods: A meta-analysis of prospective clinica...
Saved in:
Published in | Blood Vol. 144; no. Supplement 1; p. 6713 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
05.11.2024
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!